Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 1;39(41):6017-6018.
doi: 10.1016/j.vaccine.2021.08.006. Epub 2021 Aug 10.

The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action

John G Rizk  1 , Charles E Barr  2 , Youssef Rizk  3 , John C Lewin  4
Affiliations

The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action

John G Rizk et al. Vaccine. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Rizk J.G., Gupta A., Sardar P. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis [published online ahead of print, 2021 Aug 10] JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2021.3444. - DOI - PubMed
    1. See I., Su J.R., Lale A., Woo E.J., Guh A.Y., Shimabukuro T.T., et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination. JAMA. 2021;325(24):2448. doi: 10.1001/jama.2021.7517. - DOI - PMC - PubMed
    1. MacNeil J.R., Su J.R., Broder K.R., et al. Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients — United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:651–656. doi: 10.15585/mmwr.mm7017e4. - DOI - PMC - PubMed
    1. Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi: 10.1056/NEJMoa2104840. - DOI - PMC - PubMed
    1. Schultz N.H., Sørvoll I.H., Michelsen A.E., Munthe L.A., Lund-Johansen F., Ahlen M.T., et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384(22):2124–2130. doi: 10.1056/NEJMoa2104882. - DOI - PMC - PubMed